Pathway Financial Advisers’s MetLife MET Stock Holding History

Pathway Financial Advisers’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.06M	Buy	24,359 +91	+0.4%	+$7.34K	0.52%	69
2026 Q1	$1.72M	Sell	24,268 -1,019	-4%	-$76.3K	0.49%	71
2025 Q4	$2M	Sell	25,287 -47	-0.2%	-$3.72K	0.58%	62
2025 Q3	$2.08M	Sell	25,334 -1,319	-5%	-$104K	0.61%	62
2025 Q2	$2.14M	Buy	26,653 +750	+3%	+$57.9K	0.69%	50
2025 Q1	$2.08M	Sell	25,903 -193	-0.7%	-$16.1K	0.71%	48
2024 Q4	$2.14M	Sell	26,096 -215	-0.8%	-$17.9K	0.72%	46
2024 Q3	$2.19M	Sell	26,311 -385	-1%	-$28.8K	0.99%	35
2024 Q2	$1.87M	Sell	26,696 -476	-2%	-$34K	0.67%	48
2024 Q1	$2.01M	Sell	27,172 -761	-3%	-$53K	0.72%	48
2023 Q4	$1.85M	Buy	27,933 +148	+0.5%	+$9.26K	0.7%	49
2023 Q3	$1.75M	Buy	+27,785	New	+$1.73M	0.72%	49
2023 Q1	$1.58M	Sell	27,188 -245	-0.9%	-$16.5K	0.63%	57
2022 Q4	$1.99M	Buy	+27,433	New	+$1.96M	0.8%	42

Other funds holding MET

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Pathway Financial Advisers's MET Position: Q2 2026 in Review

Pathway Financial Advisers increased its MetLife (MET) stake by 0.37% in Q2 2026, buying an estimated $7.34K and bringing the position to 24,359 shares worth $2.06M. The position accounts for 0.52% of the portfolio, ranked #69.

Pathway Financial Advisers first reported a position in MET in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.19M in Q3 2024. 1,445 funds tracked by Wall St. Rank hold MET as of Q2 2026.

Pathway Financial Advisers held 24,359 shares of MetLife worth $2.06M as of Q2 2026.
Pathway Financial Advisers bought 91 MetLife shares in Q2 2026, an estimated $7.34K.
MetLife made up 0.52% of Pathway Financial Advisers's portfolio in Q2 2026, its #69 holding.
Pathway Financial Advisers first reported a position in MetLife in Q4 2022 and has held it in 14 quarters since.
Pathway Financial Advisers's MetLife position peaked at $2.19M in Q3 2024.
1,445 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Pathway Financial Advisers's 13F filing for Q2 2026, filed 30 Jul 2026.